PATENT CLAIM ANALYSIS

Application Number: 15745903
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "734000"]

Abstract:
Peritoneal therapeutic fluid comprising one or more of a biocompatibility enhancing agent (BCA) that is selected from the group consisting of a polyphenolic compound, a metabolite of a polyphenolic compound which is obtained by metabolization in the human or animal body, a salt or a glycoside of a polyphenolic compound.

Claim (Index 7):
A peritoneal therapeutic fluid according to  claim 1 , wherein the biocompatibility enhancing agent is solubilized through pegylation with Polyethyleneglycol (PEG) or Methoxy-Polyethyleneglycol (mPEG), provided that the BCA is not polyethylene glycol (PEG) or a derivative of a polyethylene glycol.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 86.0
- Lexical Diversity: 1.48649
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15523591', '11997765', '14084793', '13984991', '11554056']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7428226741278208
- 35 USC 102 Novelty (BERT): 0.5036824272106593
- Combined Prediction Score: 0.7189086494361046
- Mean Citation Score: 187.43985
- Max Citation Score: 194.85373
- Similarity Product: 117.7446895246893

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test